Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomis... von Stupp, Roger, Prof, Hegi, Monika E, PhD, Gorlia, Thierry, PhD, Erridge, Sara C, MD, Perry, James, MD, Hong, Yong-Kil, Prof, Aldape, Kenneth D, Prof, Lhermitte, Benoit, MD, Pietsch, Torsten, Prof, Grujicic, Danica, Prof, Steinbach, Joachim Peter, Prof, Wick, Wolfgang, Prof, Tarnawski, Rafał, Prof, Nam, Do-Hyun, Prof, Hau, Peter, Prof, Weyerbrock, Astrid, MD, Taphoorn, Martin J B, Prof, Shen, Chiung-Chyi, MD, Rao, Nalini, MD, Thurzo, László, MD, Herrlinger, Ulrich, MD, Gupta, Tejpal, MD, Kortmann, Rolf-Dieter, Prof, Adamska, Krystyna, MD, McBain, Catherine, MD, Brandes, Alba A, MD, Tonn, Joerg Christian, Prof, Schnell, Oliver, MD, Wiegel, Thomas, Prof, Kim, Chae-Yong, MD, Nabors, Louis Burt, MD, Reardon, David A, MD, van den Bent, Martin J, Prof, Hicking, Christine, MSc, Markivskyy, Andriy, MD, Picard, Martin, PhD, Weller, Michael, Prof

Volltext

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702 von Fiveash, John B, Ye, Xiaobu, Peerboom, David M, Mikkelsen, Tom, Chowdhary, Sajeel, Rosenfeld, Myrna, Lesser, Glenn J, Fisher, Joy, Desideri, Serena, Grossman, Stuart, Leopold, Lance, Nabors, Louis B

Volltext

Glioma-initiating cells at tumor edge gain signals from tumor core cells to promote their malignancy von Bastola, Soniya, Pavlyukov, Marat S., Yamashita, Daisuke, Ghosh, Sadashib, Cho, Heejin, Kagaya, Noritaka, Zhang, Zhuo, Minata, Mutsuko, Lee, Yeri, Sadahiro, Hirokazu, Yamaguchi, Shinobu, Komarova, Svetlana, Yang, Eddy, Markert, James, Nabors, Louis B., Bhat, Krishna, Lee, James, Chen, Qin, Crossman, David K., Shin-Ya, Kazuo, Nam, Do-Hyun, Nakano, Ichiro

Volltext

Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States von Grossman, Stuart A, Ye, Xiaobu, Piantadosi, Steven, Desideri, Serena, Nabors, Louis B, Rosenfeld, Myrna, Fisher, Joy

Volltext

ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity von Filippova, Natalia, Nabors, Louis B.

Volltext

The versatile role of HuR in Glioblastoma and its potential as a therapeutic target for a multi-pronged attack von Guha, Abhishek, Waris, Saboora, Nabors, Louis B., Filippova, Natalia, Gorospe, Myriam, Kwan, Thaddaeus, King, Peter H.

Volltext

Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study von Fathallah-Shaykh, Hassan M, DeAtkine, Andrew, Coffee, Elizabeth, Khayat, Elias, Bag, Asim K, Han, Xiaosi, Warren, Paula Province, Bredel, Markus, Fiveash, John, Markert, James, Bouaynaya, Nidhal, Nabors, Louis B

Volltext

Glioblastoma Clinical Trials: Current Landscape and Opportunities for Improvement von Bagley, Stephen J, Kothari, Shawn, Rahman, Rifaquat, Lee, Eudocia Q, Dunn, Gavin P, Galanis, Evanthia, Chang, Susan M, Nabors, Louis Burt, Ahluwalia, Manmeet S, Stupp, Roger, Mehta, Minesh P, Reardon, David A, Grossman, Stuart A, Sulman, Erik P, Sampson, John H, Khagi, Simon, Weller, Michael, Cloughesy, Timothy F, Wen, Patrick Y, Khasraw, Mustafa

Volltext

Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial von Reardon, David A., Desjardins, Annick, Vredenburgh, James J., O'Rourke, Donald M., Tran, David D., Fink, Karen L., Nabors, Louis B., Li, Gordon, Bota, Daniela A., Lukas, Rimas V., Ashby, Lynn S., Duic, J. Paul, Mrugala, Maciej M., Cruickshank, Scott, Vitale, Laura, He, Yi, Green, Jennifer A., Yellin, Michael J., Turner, Christopher D., Keler, Tibor, Davis, Thomas A., Sampson, John H.

Volltext

SRI‐42127, a novel small molecule inhibitor of the RNA regulator HuR, potently attenuates glial activation in a model of lipopolysaccharide‐induced neuroinflammation von Chellappan, Rajeshwari, Guha, Abhishek, Si, Ying, Kwan, Thaddaeus, Nabors, Louis B., Filippova, Natalia, Yang, Xiuhua, Myneni, Anish S., Meesala, Shriya, Harms, Ashley S., King, Peter H.

Volltext

Phase Ib Trial of Mutant Herpes Simplex Virus G207 Inoculated Pre-and Post-tumor Resection for Recurrent GBM von Markert, James M, Liechty, Peter G, Wang, Wenquan, Gaston, Shanna, Braz, Eunice, Karrasch, Matthias, Nabors, Louis B, Markiewicz, Michael, Lakeman, Alfred D, Palmer, Cheryl A, Parker, Jacqueline N, Whitley, Richard J, Gillespie, George Y

Volltext

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma von Reardon, David A, Nabors, Louis B, Mason, Warren P, Perry, James R, Shapiro, William, Kavan, Petr, Mathieu, David, Phuphanich, Surasak, Cseh, Agnieszka, Fu, Yali, Cong, Julie, Wind, Sven, Eisenstat, David D

Volltext

Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial von Lassman, Andrew B, van den Bent, Martin J, Gan, Hui K, Reardon, David A, Kumthekar, Priya, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B, Papadopoulos, Kyriakos P, Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M, Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Ansell, Peter J, Bain, Earle, Holen, Kyle D, Maag, David, Merrell, Ryan

Volltext

Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study von van den Bent, Martin, Gan, Hui K., Lassman, Andrew B., Kumthekar, Priya, Merrell, Ryan, Butowski, Nicholas, Lwin, Zarnie, Mikkelsen, Tom, Nabors, Louis B., Papadopoulos, Kyriakos P., Penas-Prado, Marta, Simes, John, Wheeler, Helen, Walbert, Tobias, Scott, Andrew M., Gomez, Erica, Lee, Ho-Jin, Roberts-Rapp, Lisa, Xiong, Hao, Bain, Earle, Ansell, Peter J., Holen, Kyle D., Maag, David, Reardon, David A.

Volltext

Targeting the HuR Oncogenic Role with a New Class of Cytoplasmic Dimerization Inhibitors von Filippova, Natalia, Yang, Xiuhua, Ananthan, Subramaniam, Calano, Jennifer, Pathak, Vibha, Bratton, Larry, Vekariya, Rakesh H., Zhang, Sixue, Ofori, Edward, Hayward, Emily N., Namkoong, David, Crossman, David K., Crowley, Michael R., King, Peter H., Mobley, James, Nabors, Louis B.

Volltext

Ipilimumab-induced encephalopathy with a reversible splenial lesion von Conry, Robert M, Sullivan, Joseph C, Nabors, 3rd, Louis B

Volltext

Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study von Schaff, Lauren R, Lobbous, Mina, Carlow, Dean, Schofield, Ryan, Gavrilovic, Igor T, Miller, Alexandra M, Stone, Jacqueline B, Piotrowski, Anna F, Sener, Ugur, Skakodub, Anna, Acosta, Edward P, Ryan, Kevin J, Mellinghoff, Ingo K, DeAngelis, Lisa M, Nabors, Louis B, Grommes, Christian

Volltext

An Update on Neurofibromatosis Type 1-Associated Gliomas von Lobbous, Mina, Bernstock, Joshua D., Coffee, Elizabeth, Friedman, Gregory K., Metrock, Laura K., Chagoya, Gustavo, Elsayed, Galal, Nakano, Ichiro, Hackney, James R., Korf, Bruce R., Nabors, Louis B.

Volltext

Medical decision-making capacity in patients with malignant glioma von Triebel, Kristen L, Martin, Roy C, Nabors, Louis B, Marson, Daniel C

Volltext

Undesired impact of iron supplement on MRI assessment of post-treatment glioblastoma von Park, Dahye, Lobbous, Mina, Nabors, Louis B, Markert, James M, Kim, Jinsuh

Volltext